Graft-versus-host-disease (GVHD) is a major complication of major histocompatibility complex (MHC) matched bone marrow transplantation. GVHD is the result of an immune-mediated attack, by T lymphocytes derived from donor bone marrow, against recipient tissues expressing minor histocompatibility antigen (miHA) differences. There is a lack of knowledge concerning the nature of in vivo immune responses to miHA during GVHD. C57BL/6By(B6/By) and BALB.B mouse strains both express the H-2$\sp{\rm b}$ MHC haplotype but differ at more than 40 miHA loci. Both the in vitro and in vivo T cell responses to miHA expressed by BALB.B and CXB recombinant inbred (RI) strains of mice (CXBE, G, I, J and K) are governed by immunodominance. There are disparities...
To determine whether a disparity at a single miH genetic loci are sufficient to generate GVHD in mic...
There is growing clinical interest in the utilization of mesenchymal stem cells (MSCs) in the manage...
Background: Graft versus host disease (GvHD) occurs in 20% of cases with patients having an MHC I ma...
Graft-versus-host-disease (GVHD) is a major complication of major histocompatibility complex (MHC) m...
Graft-versus-host-disease (GVHD) is a major complication of major histocompatibility complex (MHC) m...
AbstractCXB-2/By (CXB-2) recombinant inbred mice express a subset of the minor histocompatibility an...
AbstractGraft-versus-host disease (GVHD) can be induced in lethally irradiated mice after allogeneic...
C57BL/6J→ C.B10-H2b (B6→BALB.B) bone marrow transplantation (BMT) provides a major histocompatibilit...
AbstractLethal graft-versus-host disease (GVHD) can be induced after hematopoietic stem cell transpl...
Immunodominance affects the in vitro generation of cytotoxic T lymphocytes (CTL) specific for minor ...
Hematopoietic stem cell transplantation (HSCT) is an affective treatment for many malignant diseases...
AbstractAlthough CD4+ T cells can have an important role in mediating lethal graft-versus-host disea...
T cell repertoire alterations occurring after allogeneic BMT and related emergence of aGVHD has not ...
A graft-vs-host reaction (GVHR) develops after major histocompatibility complex (MHC)-compatible bon...
MHC-matched hemopoietic stem cell transplantation is commonly used for the treatment of some forms o...
To determine whether a disparity at a single miH genetic loci are sufficient to generate GVHD in mic...
There is growing clinical interest in the utilization of mesenchymal stem cells (MSCs) in the manage...
Background: Graft versus host disease (GvHD) occurs in 20% of cases with patients having an MHC I ma...
Graft-versus-host-disease (GVHD) is a major complication of major histocompatibility complex (MHC) m...
Graft-versus-host-disease (GVHD) is a major complication of major histocompatibility complex (MHC) m...
AbstractCXB-2/By (CXB-2) recombinant inbred mice express a subset of the minor histocompatibility an...
AbstractGraft-versus-host disease (GVHD) can be induced in lethally irradiated mice after allogeneic...
C57BL/6J→ C.B10-H2b (B6→BALB.B) bone marrow transplantation (BMT) provides a major histocompatibilit...
AbstractLethal graft-versus-host disease (GVHD) can be induced after hematopoietic stem cell transpl...
Immunodominance affects the in vitro generation of cytotoxic T lymphocytes (CTL) specific for minor ...
Hematopoietic stem cell transplantation (HSCT) is an affective treatment for many malignant diseases...
AbstractAlthough CD4+ T cells can have an important role in mediating lethal graft-versus-host disea...
T cell repertoire alterations occurring after allogeneic BMT and related emergence of aGVHD has not ...
A graft-vs-host reaction (GVHR) develops after major histocompatibility complex (MHC)-compatible bon...
MHC-matched hemopoietic stem cell transplantation is commonly used for the treatment of some forms o...
To determine whether a disparity at a single miH genetic loci are sufficient to generate GVHD in mic...
There is growing clinical interest in the utilization of mesenchymal stem cells (MSCs) in the manage...
Background: Graft versus host disease (GvHD) occurs in 20% of cases with patients having an MHC I ma...